Mid-term meeting for H2020 Eureka Eurostar OralG project
In January the consortium in the H2020 Eureka Eurostar OralG project had a two day mid-term meeting where the French partners visited us here in Oslo
Back: Didier Ritter (Régentis-Pharma), Håvard J Haugen (Corticalis), Joseph Lorang (LORANG). Front: Anne Agger (UiO), Janne E. Reseland ( UiO), Anaïs Vaissière (Régentis-Pharma). Foto: Astrid Skiftesvik Bjørkeng OD/UIO
The european research project has been named OralG, and is about developing a new medical device gel that reduces chronic inflammation and restores oral soft tissue health.The product will initially be tested on cells and artificial tissue, but a plan will also be developed for how the product can be used clinically.
The Eurostars Programme is a joint programme between EUREKA and the European Commission and the first European funding and support programme to be specifically dedicated to research-performing SMEs. Eurostars stimulates them to lead international collaborative research and innovation projects by easing access to support and funding.